Self-assembled nanovaccine based on apoferritin: Development and vaccine regimen evaluation
- 28 November 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 206, 114589
Abstract
No abstract availableKeywords
Funding Information
- National Council for Scientific and Technological Development
- Coordination of Higher Education Personnel Improvement
- State of São Paulo Research Foundation
This publication has 43 references indexed in Scilit:
- Self-assembled ferritin-based nanoparticles elicit a robust broad-spectrum protective immune response against SARS-CoV-2 variantsInternational Journal of Biological Macromolecules, 2024
- Ferritin‐based drug delivery system for tumor therapyBMEMat, 2023
- Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infectionBiomedicine & Pharmacotherapy, 2022
- Nanovaccine‐Based Strategies to Overcome Challenges in the Whole Vaccination Cascade for Tumor ImmunotherapySmall, 2021
- Recombinant ferritin nanoparticles can induce dendritic cell maturation through TLR4/NF-κB pathwayBiotechnology Letters, 2020
- Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapyFrontiers of Medicine, 2019
- Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding SiteCell, 2015
- Encapsulation of β-carotene within ferritin nanocages greatly increases its water-solubility and thermal stabilityFood Chemistry, 2014
- Expression of Epidermal Growth Factor Receptor variant III in laryngeal carcinoma tissuesAuris Nasus Larynx, 2009
- Structural homology between mouse liver and horse spleen ferritinsFEBS Letters, 1985